Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells

Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

Bonnie W. Ramsey, Margaret S. Pepe, Joanne Quan et al. · New England Journal of Medicine · 1999 · 1.3K citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +15

Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis and<i>CFTR</i>Stop Mutations

Michael Wilschanski, Yaacov Yahav, Yasmin Yaacov et al. · New England Journal of Medicine · 2003 · 493 citations · Full text

Medicine, Genetics, Pharmacology +16

Use of Solid Corrugated Particles to Enhance Powder Aerosol Performance

Nora Y.K. Chew, Hak‐Kim Chan · Pharmaceutical Research · 2001 · 249 citations

Natural Sciences, Materials Engineering, Materials Science +12

Evidence that Systemic Gentamicin Suppresses Premature Stop Mutations in Patients with Cystic Fibrosis

John P. Clancy, Zsuzsa Bebők, F. Ruiz et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 249 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.

Paul M. Mendelman, Arnold L. Smith, Jack Lévy et al. · PubMed · 1985 · 218 citations

Medicine, Microbiology, Pharmacology +13